X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1305) 1305
Book Review (140) 140
Newsletter (96) 96
Publication (45) 45
Magazine Article (35) 35
Newspaper Article (28) 28
Conference Proceeding (8) 8
Book Chapter (4) 4
Dissertation (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (999) 999
humans (962) 962
aids/hiv (761) 761
zalcitabine - therapeutic use (472) 472
zalcitabine (444) 444
hiv infections - drug therapy (404) 404
zidovudine - therapeutic use (360) 360
drug therapy, combination (349) 349
zalcitabine - pharmacology (342) 342
zidovudine (318) 318
zalcitabine - analogs & derivatives (288) 288
animals (273) 273
male (263) 263
acquired immunodeficiency syndrome - drug therapy (239) 239
pharmacology & pharmacy (238) 238
aids (237) 237
didanosine - therapeutic use (233) 233
lamivudine (231) 231
zalcitabine - administration & dosage (222) 222
drug therapy (203) 203
female (203) 203
antiviral agents - therapeutic use (201) 201
adult (199) 199
zidovudine - pharmacology (188) 188
hiv-1 - drug effects (183) 183
hiv (177) 177
antiviral agents - pharmacology (175) 175
zidovudine - administration & dosage (174) 174
anti-hiv agents - therapeutic use (168) 168
didanosine (168) 168
infectious diseases (164) 164
cd4 lymphocyte count (142) 142
abridged index medicus (141) 141
zalcitabine - adverse effects (140) 140
immunology (131) 131
reverse transcriptase inhibitors - therapeutic use (122) 122
virology (120) 120
hiv infection (116) 116
human-immunodeficiency-virus (116) 116
antiviral agents (104) 104
hiv - drug effects (104) 104
virus replication - drug effects (103) 103
cell line (99) 99
zidovudine - adverse effects (95) 95
didanosine - pharmacology (93) 93
biochemistry & molecular biology (91) 91
evaluation (91) 91
mice (90) 90
antiviral agents - administration & dosage (89) 89
zalcitabine - pharmacokinetics (89) 89
reverse transcriptase inhibitors - pharmacology (88) 88
hiv-1 - genetics (87) 87
microbiology (87) 87
cells, cultured (86) 86
middle aged (84) 84
aids-related complex (83) 83
therapy (82) 82
2',3'-dideoxycytidine (80) 80
didanosine - administration & dosage (80) 80
hiv protease inhibitors - therapeutic use (79) 79
hiv-1 (79) 79
infection (79) 79
zalcitabine - toxicity (79) 79
clinical trials as topic (78) 78
invitro (78) 78
anti-hiv agents - pharmacology (76) 76
rats (76) 76
drug resistance, microbial (73) 73
medicine, general & internal (72) 72
dose-response relationship, drug (71) 71
replication (71) 71
human immunodeficiency virus (69) 69
viral load (68) 68
hiv infections - immunology (67) 67
hiv infections - virology (67) 67
health aspects (66) 66
stavudine - therapeutic use (65) 65
antiretroviral therapy (63) 63
mutation (63) 63
reverse-transcriptase (63) 63
anti-hiv agents - administration & dosage (62) 62
dideoxynucleosides - pharmacology (62) 62
combination therapy (60) 60
time factors (60) 60
zalcitabine - metabolism (60) 60
base sequence (59) 59
didanosine - adverse effects (58) 58
kinetics (58) 58
molecular sequence data (58) 58
reverse transcriptase inhibitors (58) 58
rna, viral - blood (58) 58
toxicity (57) 57
drug resistance (56) 56
3'-azido-3'-deoxythymidine (55) 55
antiviral agents - adverse effects (55) 55
drug interactions (55) 55
placebo-controlled trial (54) 54
anti-hiv agents - adverse effects (53) 53
lamivudine - therapeutic use (53) 53
phosphorylation (53) 53
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1389) 1389
Spanish (24) 24
German (21) 21
French (11) 11
Japanese (7) 7
Dutch (5) 5
Portuguese (4) 4
Italian (3) 3
Russian (2) 2
Chinese (1) 1
Danish (1) 1
Hebrew (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The EMBO Journal, ISSN 0261-4189, 07/2015, Volume 34, Issue 14, pp. 1959 - 1970
Journal Article
Biomaterials, ISSN 0142-9612, 2013, Volume 34, Issue 20, pp. 4831 - 4838
Journal Article
Journal Article
Journal Article
Journal of Biological Chemistry, ISSN 0021-9258, 06/2001, Volume 276, Issue 26, pp. 23832 - 23837
Several of the nucleoside analogs used in the treatment of AIDS exhibit a delayed clinical toxicity limiting their usefulness. The toxicity of nucleoside... 
DNA-POLYMERASE-GAMMA | SUBSTRATE-SPECIFICITY | (-)-2'-DEOXY-3'-THIACYTIDINE 3TC | NUCLEOSIDE ANALOGS | CHRONIC HEPATITIS-B | BIOCHEMISTRY & MOLECULAR BIOLOGY | IMMUNODEFICIENCY-VIRUS INFECTION | FIALURIDINE FIAU | HIV-1 REVERSE-TRANSCRIPTASE | PHARMACOKINETIC PROPERTIES | SUBUNIT | Anti-HIV Agents - pharmacology | DNA Polymerase gamma | Deoxycytosine Nucleotides - pharmacology | DNA Replication - drug effects | Humans | Cytidine Triphosphate - metabolism | Reverse Transcriptase Inhibitors - pharmacology | Zalcitabine - pharmacology | Exodeoxyribonucleases - antagonists & inhibitors | Lamivudine - analogs & derivatives | Lamivudine - adverse effects | Reverse Transcriptase Inhibitors - adverse effects | Nucleic Acid Synthesis Inhibitors | DNA - biosynthesis | Deoxycytosine Nucleotides - metabolism | Anti-HIV Agents - metabolism | Zalcitabine - adverse effects | Cytidine Triphosphate - pharmacology | DNA, Mitochondrial - metabolism | Anti-HIV Agents - adverse effects | Lamivudine - metabolism | Zalcitabine - metabolism | Mitochondria - drug effects | Acquired Immunodeficiency Syndrome - drug therapy | Cytidine Triphosphate - adverse effects | Cytidine Triphosphate - analogs & derivatives | Deoxycytosine Nucleotides - adverse effects | Lamivudine - pharmacology | Reverse Transcriptase Inhibitors - metabolism | DNA-Directed DNA Polymerase - metabolism | Dideoxynucleotides | Kinetics | Zalcitabine | Lamivudine | nucleosides | Index Medicus
Journal Article
Journal Article
Journal of Immunology, ISSN 0022-1767, 12/2013, Volume 191, Issue 12, pp. 6060 - 6070
The programmed cell death-1 (PD-1)/programmed cell death ligand-1 pathway has been shown to limit cell-mediated effector functions during chronic viral... 
POPULATION | HIV-INFECTION | REPLICATION | AUTOIMMUNITY | DYSFUNCTION | IMMUNOLOGY | CHRONIC VIRAL-INFECTION | PHASE-I | EXPRESSION | EXHAUSTION | DISEASE PROGRESSION | Recombinant Proteins - therapeutic use | Lymphokines - secretion | Zalcitabine - analogs & derivatives | Antibodies, Monoclonal - therapeutic use | Programmed Cell Death 1 Receptor - antagonists & inhibitors | RNA, Viral - blood | Macaca mulatta | CD4-Positive T-Lymphocytes - immunology | Tenofovir | Simian Immunodeficiency Virus - genetics | Adenine - therapeutic use | Immunotherapy | Immunoglobulin Fc Fragments - therapeutic use | Drug Evaluation, Preclinical | Zalcitabine - therapeutic use | Anti-Retroviral Agents - therapeutic use | Adenine - analogs & derivatives | Organophosphonates - therapeutic use | Histocompatibility Antigens Class I - immunology | Solubility | Combined Modality Therapy | Recombinant Proteins - pharmacology | Viremia - drug therapy | Simian Acquired Immunodeficiency Syndrome - blood | Animals | CD4-Positive T-Lymphocytes - secretion | CD8-Positive T-Lymphocytes - secretion | Simian Acquired Immunodeficiency Syndrome - drug therapy | Simian Acquired Immunodeficiency Syndrome - immunology | CD8-Positive T-Lymphocytes - drug effects | Immunoglobulin Fc Fragments - pharmacology | Viremia - immunology | Programmed Cell Death 1 Receptor - therapeutic use | CD8-Positive T-Lymphocytes - immunology | Viremia - blood | Immunity, Cellular | CD4-Positive T-Lymphocytes - drug effects | Apoptosis | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Journal of Medicinal Chemistry, ISSN 0022-2623, 10/2004, Volume 47, Issue 21, pp. 5041 - 5048
Journal Article
Science, ISSN 0036-8075, 8/1995, Volume 269, Issue 5224, pp. 696 - 699
Combinations of antiretroviral drugs that prevent or delay the appearance of drug-resistant human immunodeficiency virus-type 1 (HIV-1) mutants are urgently... 
Polymerase chain reaction | RNA | DNA | Antivirals | Viruses | Reports | Codons | Inhibitory concentration 50 | Genetic mutation | Viral load | HIV 1 | TYPE-1 REVERSE-TRANSCRIPTASE | SUSCEPTIBILITIES | MULTIDISCIPLINARY SCIENCES | MUTATION | HIGH-LEVEL RESISTANCE | SENSITIVITY | ZIDOVUDINE AZT | AGENTS | INHIBITORS | HUMAN-IMMUNODEFICIENCY-VIRUS | Zalcitabine - analogs & derivatives | Humans | Molecular Sequence Data | Zalcitabine - pharmacology | RNA, Viral - blood | Codon | HIV-1 - growth & development | Base Sequence | HIV Reverse Transcriptase | RNA-Directed DNA Polymerase - genetics | Drug Therapy, Combination | Zalcitabine - therapeutic use | Cell Line | Antiviral Agents - pharmacology | Mutagenesis, Site-Directed | Antiviral Agents - therapeutic use | HIV-1 - drug effects | HIV Infections - virology | Zidovudine - pharmacology | Lamivudine | CD4 Lymphocyte Count | HIV-1 - genetics | Drug Resistance, Microbial | Point Mutation | HIV Infections - drug therapy | HIV-1 - enzymology | Zidovudine - therapeutic use | Reverse Transcriptase Inhibitors | HeLa Cells | Serial Passage | Antiviral agents | AIDS (Disease) | Research | Drug therapy | Drug resistance | Zidovudine | Health aspects | HIV infection | Ribonucleic acid | Human immunodeficiency virus--HIV | Medical immunity | Mutation | Human immunodeficiency virus | Ribonucleic acid--RNA | Index Medicus | AIDS/HIV
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 07/2005, Volume 49, Issue 7, pp. 2828 - 2833
Journal Article
Science, ISSN 0036-8075, 7/1997, Volume 277, Issue 5322, pp. 112 - 116
Journal Article
16.